FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Inti Zlobec

Research Profile

Disorders

Chemicals & Drugs

Procedures

Concepts & Ideas

Physiology

DNA Mismatch Repair

Anatomy

Lymphocytes, Tumor-Infiltrating

Co-author Network

Publications

TOP 3
Milo Horcic; Eva Karamitopoulou; Viktor H Koelzer; Giacomo Puppa; Luigi Terracciano; Inti Zlobec; Alessandro Lugli
Tumor budding score based on 10 high-power fields is a promising basis for a standardized prognostic scoring system in stage II colorectal cancer.
Inti Zlobec
Novel biomarkers for the prediction of metastasis in colorectal cancer.
E Karamitopoulou; A Kondi-Pafiti; D Born; Kostas Gennatas; B Gloor; P Lykoudis; A Mellou; Inti Zlobec; Alessandro Lugli
Tumour budding is a strong and independent prognostic factor in pancreatic cancer.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Inti Zlobec (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Milo Horcic; Eva Karamitopoulou; Viktor H Koelzer; Giacomo Puppa; Luigi Terracciano; Inti Zlobec; Alessandro Lugli
Tumor budding score based on 10 high-power fields is a promising basis for a standardized prognostic scoring system in stage II colorectal cancer.
Human pathology 2013;44(5):697-705.
2013: Inti Zlobec
Novel biomarkers for the prediction of metastasis in colorectal cancer.
Expert opinion on medical diagnostics 2013;7(2):137-46.
2013: E Karamitopoulou; A Kondi-Pafiti; D Born; Kostas Gennatas; B Gloor; P Lykoudis; A Mellou; Inti Zlobec; Alessandro Lugli
Tumour budding is a strong and independent prognostic factor in pancreatic cancer.
European journal of cancer (Oxford, England : 1990) 2013;49(5):1032-9.
2013: Clémentine Le Magnen; Alexander Bachmann; Lukas Bubendorf; Michael Heberer; Christian Ruiz; Giulio C Spagnoli; Stephen Wyler; Inti Zlobec; Chantal Mengus
Klf4 transcription factor is expressed in the cytoplasm of prostate cancer cells.
European journal of cancer (Oxford, England : 1990) 2013;49(4):955-63.
2013: Eva Karamitopoulou; Viktor Kölzer; Agathi Kondi-Pafiti; Efstratios S Patsouris; Inti Zlobec; Kostas Gennatas; Alessandro Lugli
Proposal for a 10-high-power-fields scoring method for the assessment of tumor budding in colorectal cancer.
Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc 2013;26(2):295-301.
2013: Jens Jakscha; Ellen C Obermann; Claudio Storck; Luigi M Terracciano; Luigi Tornillo; Inti Zlobec; Claude A Fischer
The clinical impact of p16 status in fine-needle aspirates of cervical lymph node metastasis of head and neck squamous cell carcinomas.
European archives of oto-rhino-laryngology : official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery 2013;270(2):661-7.
2012: Viktor Hendrik Koelzer; Kristi Baker; Daniel Baumhoer; Daniela Kassahn; Inti Zlobec
Prognostic impact of β-2-microglobulin expression in colorectal cancers stratified by mismatch repair status.
Journal of clinical pathology 2012;65(11):996-1002.
2012: Inti Zlobec; Alex Rufle; Michel P Bihl; Anja Foerster; Alessandro Lugli
The impact of CpG island methylator phenotype and microsatellite instability on tumour budding in colorectal cancer.
Histopathology 2012;61(5):777-87.
2012: Olivier T Giger; Alessandro Lugli; Inti Zlobec; Sarah C M Comtesse; Michael O Kurrer
Intra-tumoral budding in preoperative biopsy specimens predicts lymph node and distant metastasis in patients with colorectal cancer.
Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc 2012;25(7):1048-53.
2012: Alessandro Lugli; E Karamitopoulou; Inti Zlobec
Tumour budding: a promising parameter in colorectal cancer.
British journal of cancer 2012;106(11):1713-7.
2012: Sara Simonetti; Loredana Stasio; Luigi Terracciano; Inti Zlobec; Ergin Kilic; Guido Pettinato; Maria Quarto; Luigi Insabato
Immunophenotyping analysis in invasive micropapillary carcinoma of the breast: role of CD24 and CD44 isoforms expression.
Breast (Edinburgh, Scotland) 2012;21(2):165-70.
2012: Salvatore Piscuoglio; Romina Sepe; Luigi Terracciano; Arthur Zimmermann; Inti Zlobec; Ioannis Diamantis; Francesco Esposito; Alfredo Fusco; pierlorenzo pallante; Eva Karamitopoulou
HMGA1 and HMGA2 protein expression correlates with advanced tumour grade and lymph node metastasis in pancreatic adenocarcinoma.
Histopathology 2012;60(3):397-404.
2012: Salvatore Piscuoglio; Petra Rümmele; Fausto Sessa; Daniel Baumhoer; Wolfgang Dietmaier; Arndt Hartmann; Frank S Lehmann; Luigi Tornillo; Peter H Wünsch; Inti Zlobec; Luigi M Terracciano
Effect of EpCAM, CD44, CD133 and CD166 expression on patient survival in tumours of the ampulla of Vater.
Journal of clinical pathology 2012;65(2):140-5.
2012: Michel P Bihl; Anja Foerster; Alessandro Lugli; Inti Zlobec
Characterization of CDKN2A(p16) methylation and impact in colorectal cancer: systematic analysis using pyrosequencing.
Journal of translational medicine 2012;10():173.
2012: Inti Zlobec; Alessandro Lugli; Markus Borner; Daniel Inderbitzin
Role of intra- and peritumoral budding in the interdisciplinary management of rectal cancer patients.
International journal of surgical oncology 2012;2012():795945.
2012: Martin Oeggerli; Christian Ruiz; Matthias Sausbier; Guido Sauter; Yuemin Tian; Barbara Wijker; Inti Zlobec; Uwe Güth; Karl Kunzelmann; Ellen Obermann; Lukas Bubendorf
Role of KCNMA1 in breast cancer.
PloS one 2012;7(8):e41664.
2012: Inti Zlobec; Michel P Bihl; Anja Foerster; Alex Rufle; Luigi Terracciano; Alessandro Lugli
Stratification and Prognostic Relevance of Jass's Molecular Classification of Colorectal Cancer.
Frontiers in oncology 2012;2():7.
2012: Raoul Droeser; Uwe Güth; Michael Heberer; Ergin Kilic; Daniel Oertli; Giulio Spagnoli; Inti Zlobec; Coya Tapia
Differential pattern and prognostic significance of CD4+, FOXP3+ and IL-17+ tumor infiltrating lymphocytes in ductal and lobular breast cancers.
BMC cancer 2012;12():134.
2011: Alessandro Lugli; Efstratios S Patsouris; George Peros; Luigi M Terracciano; Tatjana Vlajnic; Olivier Giger; Eva Karamitopoulou; Inti Zlobec
Intratumoral budding as a potential parameter of tumor progression in mismatch repair-proficient and mismatch repair-deficient colorectal cancer patients.
Human pathology 2011;42(12):1833-40.
2011: Eva Karamitopoulou; Christos Lapas; Petros Karakitsos; Ioannis Panayiotides; Efstratios S Patsouris; George Peros; George Rallis; Luigi M Terracciano; Inti Zlobec; Alessandro Lugli
Systematic analysis of proteins from different signaling pathways in the tumor center and the invasive front of colorectal cancer.
Human pathology 2011;42(12):1888-96.
2011: Inti Zlobec; Alex Rufle; Michel P Bihl; Anja Foerster; Alessandro Lugli
Comprehensive analysis of CpG island methylator phenotype (CIMP)-high, -low, and -negative colorectal cancers based on protein marker expression and molecular features.
The Journal of pathology 2011;225(3):336-43.
2011: Tatjana Vlajnic; Inti Zlobec; Luigi Tornillo; Maria Carla Andreozzi; Eva Karamitopoulou; Alessandro Lugli; Christian Ruiz; Sandra Schneider; Luigi Terracciano
VEGFA gene locus (6p12) amplification identifies a small but highly aggressive subgroup of colorectal cancer [corrected] patients.
Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc 2011;24(10):1404-12.
2011: Inti Zlobec; Kristi Baker; Parham Minoo; Luigi Terracciano; Alessandro Lugli
Characterization of the immunological microenvironment of tumour buds and its impact on prognosis in mismatch repair-proficient and -deficient colorectal cancers.
Histopathology 2011;59(3):482-95.
2011: Coya Tapia; Inti Zlobec; Sandra Schneider; Lukas Bubendorf; Uwe Güth; Ergin Kilic; SuWon Kim
Deletion of the inhibitor of growth 4 (ING4) tumor suppressor gene is prevalent in human epidermal growth factor 2 (HER2)-positive breast cancer.
Human pathology 2011;42(7):983-90.
2011: Kristi Baker; Tarek A Bismar; Jonathan Lachapelle; Luigi Terracciano; Inti Zlobec; William D Foulkes
Prognostic significance of CD8+ T lymphocytes in breast cancer depends upon both oestrogen receptor status and histological grade.
Histopathology 2011;58(7):1107-16.
2011: Achim Fleischmann; Carla Rocha; Nikolina Saxer-Sekulic; Inti Zlobec; Guido Sauter; George N Thalmann
High CD10 expression in lymph node metastases from surgically treated prostate cancer independently predicts early death.
Virchows Archiv : an international journal of pathology 2011;458(6):741-8.
2011: Giuseppe Sconocchia; Inti Zlobec; Alessandro Lugli; Diego Calabrese; Giandomenica Iezzi; Eva Karamitopoulou; Efstratios S Patsouris; George Peros; Milo Horcic; Luigi Tornillo; Markus Zuber; Raoul Droeser; Manuele G Muraro; Chantal Mengus; Daniel Oertli; Soldano Ferrone; Luigi Terracciano; Giulio C Spagnoli
Tumor infiltration by FcγRIII (CD16)+ myeloid cells is associated with improved survival in patients with colorectal carcinoma.
International journal of cancer. Journal international du cancer 2011;128(11):2663-72.
2011: Inti Zlobec
Assessing downgrading of locally advanced rectal cancer after chemo-radiotherapy.
European journal of cancer (Oxford, England : 1990) 2011;47(8):1125-6.
2011: Seife Hailemariam; Jürg Vosbeck; Gieri Cathomas; Inti Zlobec; Gianfranco Mattarelli; Tobias Eichenberger; Tobias Zellweger; Alex Bachmann; Thomas C Gasser; Lukas Bubendorf
Can molecular markers stratify the diagnostic value of high-grade prostatic intraepithelial neoplasia?
Human pathology 2011;42(5):702-9.
2011: Achim Fleischmann; Carla Rocha; Nikolina Saxer-Sekulic; Inti Zlobec; Guido Sauter; George N Thalmann
High-level cytoplasmic cyclin D1 expression in lymph node metastases from prostate cancer independently predicts early biochemical failure and death in surgically treated patients.
Histopathology 2011;58(5):781-9.
2011: E Karamitopoulou; Inti Zlobec; Es Patsouris; G Peros; Alessandro Lugli
Loss of E-cadherin independently predicts the lymph node status in colorectal cancer.
Pathology 2011;43(2):133-7.
2011: Claude A Fischer; Minoa Jung; Inti Zlobec; Edith Green; Claudio Storck; Luigi Tornillo; Alessandro Lugli; Markus Wolfensberger; Luigi M Terracciano
Co-overexpression of p21 and Ki-67 in head and neck squamous cell carcinoma relative to a significantly poor prognosis.
Head & neck 2011;33(2):267-73.
2011: L Cindolo; Monica Cantile; renato franco; P Chiodini; Giulia Schiavo; I Forte; Inti Zlobec; L Salzano; Gerardo Botti; S Gidaro; Luigi Terracciano; Clemente Cillo
Parallel determination of NeuroD1, chromogranin-A, KI67 and androgen receptor expression in surgically treated prostate cancers.
International braz j urol : official journal of the Brazilian Society of Urology 2011;37(1):57-66.
2010: Inti Zlobec; Michal Kovac; Priska Erzberger; Francesca Molinari; Michel P Bihl; Alexander Rufle; Anja Foerster; Milo Frattini; Luigi Terracciano; Karl Heinimann; Alessandro Lugli
Combined analysis of specific KRAS mutation, BRAF and microsatellite instability identifies prognostic subgroups of sporadic and hereditary colorectal cancer.
International journal of cancer. Journal international du cancer 2010;127(11):2569-75.
2010: Inti Zlobec; Alessandro Lugli
Epithelial mesenchymal transition and tumor budding in aggressive colorectal cancer: tumor budding as oncotarget.
Oncotarget 2010;1(7):651-61.
2010: Inti Zlobec; Francesca Molinari; Vittoria Martin; Luca Mazzucchelli; Piercarlo Saletti; Rosangela Trezzi; Sara De Dosso; Tatjana Vlajnic; Milo Frattini; Alessandro Lugli
Tumor budding predicts response to anti-EGFR therapies in metastatic colorectal cancer patients.
World journal of gastroenterology : WJG 2010;16(38):4823-31.
2010: Eva Karamitopoulou; Inti Zlobec; ANNA KOUMARIANOU; Efstratios S Patsouris; George Peros; Alessandro Lugli
Expression of p16 in lymph node metastases of adjuvantly treated stage III colorectal cancer patients identifies poor prognostic subgroups: a retrospective analysis of biomarkers in matched primary tumor and lymph node metastases.
Cancer 2010;116(19):4474-86.
2010: Eva Karamitopoulou; Alessandro Lugli; Ioannis Panayiotides; Petros Karakitsos; George Peros; George Rallis; Efstratios S Patsouris; Luigi Terracciano; Inti Zlobec
Systematic assessment of protein phenotypes characterizing high-grade tumour budding in mismatch repair-proficient colorectal cancer.
Histopathology 2010;57(2):233-43.
2010: pierlorenzo pallante; Luigi Terracciano; Vincenza Carafa; Sandra Schneider; Inti Zlobec; Alessandro Lugli; Mimma Bianco; Angelo Ferraro; Silvana Sacchetti; Giancarlo Troncone; Alfredo Fusco; Luigi Tornillo
The loss of the CBX7 gene expression represents an adverse prognostic marker for survival of colon carcinoma patients.
European journal of cancer (Oxford, England : 1990) 2010;46(12):2304-13.
2010: Alessandro Lugli; G Iezzi; I Hostettler; M G Muraro; V Mele; Luigi Tornillo; Vincenza Carafa; Giulio C Spagnoli; Luigi Terracciano; Inti Zlobec
Prognostic impact of the expression of putative cancer stem cell markers CD133, CD166, CD44s, EpCAM, and ALDH1 in colorectal cancer.
British journal of cancer 2010;103(3):382-90.
2010: Inti Zlobec; Michel P Bihl; Heike Schwarb; Luigi Terracciano; Alessandro Lugli
Clinicopathological and protein characterization of BRAF- and K-RAS-mutated colorectal cancer and implications for prognosis.
International journal of cancer. Journal international du cancer 2010;127(2):367-80.
2010: Spasenija Savic; Noreli Franco; Bruno Grilli; Audrey Barascud; Michelle Herzog; Beata Bode; Heinz Loosli; Peter Spieler; René Schönegg; Inti Zlobec; Douglas P Clark; James G Herman; Lukas Bubendorf
Fluorescence in situ hybridization in the definitive diagnosis of malignant mesothelioma in effusion cytology.
Chest 2010;138(1):137-44.
2010: Daniel M Frey; Raoul A Droeser; Carsten T Viehl; Inti Zlobec; Alessandro Lugli; Urs Zingg; Daniel Oertli; Christoph Kettelhack; Luigi Terracciano; Luigi Tornillo
High frequency of tumor-infiltrating FOXP3(+) regulatory T cells predicts improved survival in mismatch repair-proficient colorectal cancer patients.
International journal of cancer. Journal international du cancer 2010;126(11):2635-43.
2010: Eva Karamitopoulou; pierlorenzo pallante; Inti Zlobec; Luigi Tornillo; Vincenza Carafa; Thomas Schaffner; Markus Borner; Ioannis Diamantis; Francesco Esposito; Thomas Brunner; Arthur Zimmermann; Antonella Federico; Luigi Terracciano; Alfredo Fusco
Loss of the CBX7 protein expression correlates with a more aggressive phenotype in pancreatic cancer.
European journal of cancer (Oxford, England : 1990) 2010;46(8):1438-44.
2010: Inti Zlobec; Ines Raineri; Sandra Schneider; René Schoenegg; Bruno Grilli; Michelle Herzog; Spasenija Savic; Lukas Bubendorf
Assessment of mean EGFR gene copy number is a highly reproducible method for evaluating FISH in histological and cytological cancer specimens.
Lung cancer (Amsterdam, Netherlands) 2010;68(2):192-7.
2010: Eva Karamitopoulou; Inti Zlobec; Luigi Tornillo; Vincenza Carafa; Thomas Schaffner; Thomas Brunner; Markus Borner; Ioannis Diamantis; Arthur Zimmermann; Luigi Terracciano
Differential cell cycle and proliferation marker expression in ductal pancreatic adenocarcinoma and pancreatic intraepithelial neoplasia (PanIN).
Pathology 2010;42(3):229-34.
2010: Claude A Fischer; Inti Zlobec; Edith Green; Simone Probst; Claudio Storck; Alessandro Lugli; Luigi Tornillo; Markus Wolfensberger; Luigi Terracciano
Is the improved prognosis of p16 positive oropharyngeal squamous cell carcinoma dependent of the treatment modality?
International journal of cancer. Journal international du cancer 2010;126(5):1256-62.
2010: Lsabel Hostettler; Inti Zlobec; Luigi Terracciano; Alessandro Lugli
ABCG5-positivity in tumor buds is an indicator of poor prognosis in node-negative colorectal cancer patients.
World journal of gastroenterology : WJG 2010;16(6):732-9.
2010: Alexandar Tzankov; Inti Zlobec; Philip Thomas Went; Hannes Robl; Sylvia Hoeller; Stephan Dirnhofer
Prognostic immunophenotypic biomarker studies in diffuse large B cell lymphoma with special emphasis on rational determination of cut-off scores.
Leukemia & lymphoma 2010;51(2):199-212.
2010: Inti Zlobec; F Molinari; M Kovac; Michel P Bihl; H J Altermatt; J Diebold; H Frick; M Germer; Milo Horcic; matteo montani; Gad Singer; H Yurtsever; A Zettl; Luigi Terracciano; L Mazzucchelli; Piercarlo Saletti; M Frattini; Karl Heinimann; Alessandro Lugli
Prognostic and predictive value of TOPK stratified by KRAS and BRAF gene alterations in sporadic, hereditary and metastatic colorectal cancer patients.
British journal of cancer 2010;102(1):151-61.
2010: Inti Zlobec; Eva Karamitopoulou; Luigi Terracciano; Salvatore Piscuoglio; Giandomenica Iezzi; Manuele Giuseppe Muraro; Giulio Spagnoli; Kristi Baker; Alexandar Tzankov; Alessandro Lugli
TIA-1 cytotoxic granule-associated RNA binding protein improves the prognostic performance of CD8 in mismatch repair-proficient colorectal cancer.
PloS one 2010;5(12):e14282.
2010: Inti Zlobec; Parham Minoo; Eva Karamitopoulou; George Peros; Efstratios S Patsouris; Frank Lehmann; Alessandro Lugli
Role of tumor size in the pre-operative management of rectal cancer patients.
BMC gastroenterology 2010;10():61.
2010: Manuela Eppenberger; Inti Zlobec; Daniel Baumhoer; Luigi Terracciano; Alessandro Lugli
Role of the VEGF ligand to receptor ratio in the progression of mismatch repair-proficient colorectal cancer.
BMC cancer 2010;10():93.
2010: Sylvia Hoeller; Deborah Zihler; Inti Zlobec; Ellen C Obermann; Stefano A Pileri; Stephan Dirnhofer; Alexandar Tzankov
BOB.1, CD79a and cyclin E are the most appropriate markers to discriminate classical Hodgkin's lymphoma from primary mediastinal large B-cell lymphoma.
Histopathology 2010;56(2):217-28.
2010: Parham Minoo; Kristi Baker; Daniel Baumhoer; Luigi Terracciano; Alessandro Lugli; Inti Zlobec
Urokinase-type plasminogen activator is a marker of aggressive phenotype and an independent prognostic factor in mismatch repair-proficient colorectal cancer.
Human pathology 2010;41(1):70-8.
2009: Inti Zlobec; Alessandro Lugli
Invasive front of colorectal cancer: dynamic interface of pro-/anti-tumor factors.
World journal of gastroenterology : WJG 2009;15(47):5898-906.
2009: Inti Zlobec; Ursula Günthert; Luigi Tornillo; Giandomenica Iezzi; Daniel Baumhoer; Luigi Terracciano; Alessandro Lugli
Systematic assessment of the prognostic impact of membranous CD44v6 protein expression in colorectal cancer.
Histopathology 2009;55(5):564-75.
2009: H Adams; Alexandar Tzankov; Alessandro Lugli; Inti Zlobec
New time-dependent approach to analyse the prognostic significance of immunohistochemical biomarkers in colon cancer and diffuse large B-cell lymphoma.
Journal of clinical pathology 2009;62(11):986-97.
2009: Alessandro Lugli; E Karamitopoulou; I Panayiotides; Petros Karakitsos; G Rallis; G Peros; G Iezzi; Giulio C Spagnoli; Michel P Bihl; Luigi Terracciano; Inti Zlobec
CD8+ lymphocytes/ tumour-budding index: an independent prognostic factor representing a 'pro-/anti-tumour' approach to tumour host interaction in colorectal cancer.
British journal of cancer 2009;101(8):1382-92.
2009: Monica Cantile; renato franco; Adrienne Tschan; Daniel Baumhoer; Inti Zlobec; Giulia Schiavo; Iris Forte; Michel Bihl; Giuseppina Liguori; Gerardo Botti; Luigi Tornillo; Eva Karamitopoulou-Diamantis; Luigi Terracciano; Clemente Cillo
HOX D13 expression across 79 tumor tissue types.
International journal of cancer. Journal international du cancer 2009;125(7):1532-41.
2009: Inti Zlobec; Kristi Baker; Parham Minoo; Shinichi Hayashi; Luigi Terracciano; Alessandro Lugli
Tumor border configuration added to TNM staging better stratifies stage II colorectal cancer patients into prognostic subgroups.
Cancer 2009;115(17):4021-9.
2009: Coya Tapia; Spasenija Savic; Michel P Bihl; Alex Rufle; Inti Zlobec; Luigi Terracciano; Lukas Bubendorf
[EGFR mutation analysis in non-small-cell lung cancer : Experience from routine diagnostics].
Der Pathologe 2009;30(5):384-92.
2009: Spasenija Savic; Inti Zlobec; George N Thalmann; Daniel Engeler; Martina Schmauss; Kurt Lehmann; Gianfranco Mattarelli; Tobias Eichenberger; Peter Dalquen; Peter Spieler; René Schoenegg; Thomas C Gasser; Tullio Sulser; Thomas Forster; Tobias Zellweger; Roberto Casella; Lukas Bubendorf
The prognostic value of cytology and fluorescence in situ hybridization in the follow-up of nonmuscle-invasive bladder cancer after intravesical Bacillus Calmette-Guérin therapy.
International journal of cancer. Journal international du cancer 2009;124(12):2899-904.
2009: Inti Zlobec; Sylvia Höller; Luigi Tornillo; Luigi Terracciano; Alessandro Lugli
Combined histomorphologic and immunohistochemical phenotype to predict the presence of vascular invasion in colon cancer.
Diseases of the colon and rectum 2009;52(6):1114-21.
2009: Tobias Zellweger; Sarah Günther; Inti Zlobec; Spasenija Savic; Guido Sauter; Holger Moch; Gianfranco Mattarelli; Tobias Eichenberger; Enrico Curschellas; Hansjörg Rüfenacht; Alexander Bachmann; Thomas C Gasser; Michael J Mihatsch; Lukas Bubendorf
Tumour growth fraction measured by immunohistochemical staining of Ki67 is an independent prognostic factor in preoperative prostate biopsies with small-volume or low-grade prostate cancer.
International journal of cancer. Journal international du cancer 2009;124(9):2116-23.
2009: Daniel Baumhoer; Marc-Oliver Riener; Inti Zlobec; Luigi Tornillo; Alexander Vogetseder; Glen Kristiansen; Wolfgang Dietmaier; Arndt Hartmann; Peter H Wuensch; Fausto Sessa; Petra Ruemmele; Luigi M Terracciano
Expression of CD24, P-cadherin and S100A4 in tumors of the ampulla of Vater.
Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc 2009;22(2):306-13.
2008: Daniel Baumhoer; Inti Zlobec; Luigi Tornillo; Wolfgang Dietmaier; Peter H Wuensch; Arndt Hartmann; Fausto Sessa; Petra Ruemmele; Luigi Terracciano
Immunophenotyping and oncogene amplifications in tumors of the papilla of Vater.
Virchows Archiv : an international journal of pathology 2008;453(6):579-88.
2008: Inti Zlobec; Kristi Baker; Luigi Terracciano; S Peter; L Degen; C Beglinger; Alessandro Lugli
Two-marker protein profile predicts poor prognosis in patients with early rectal cancer.
British journal of cancer 2008;99(10):1712-7.
2008: Eva Karamitopoulou; Luigi Tornillo; Inti Zlobec; Lukas Cioccari; Vincenza Carafa; Markus Borner; Thomas Schaffner; Thomas Brunner; Ioannis Diamantis; Arthur Zimmermann; Luigi Terracciano
Clinical significance of cell cycle- and apoptosis-related markers in biliary tract cancer: a tissue microarray-based approach revealing a distinctive immunophenotype for intrahepatic and extrahepatic cholangiocarcinomas.
American journal of clinical pathology 2008;130(5):780-6.
2008: Claude Fischer; Inti Zlobec; Edith Stöckli; Simone Probst; Claudio Storck; Luigi Tornillo; Alessandro Lugli; Markus Wolfensberger; Luigi Terracciano
Is immunohistochemical epidermal growth factor receptor expression overestimated as a prognostic factor in head-neck squamous cell carcinoma? A retrospective analysis based on a tissue microarray of 365 carcinomas.
Human pathology 2008;39(10):1527-34.
2008: Inti Zlobec; Luigi Terracciano; Luigi Tornillo; U Günthert; T Vuong; Jeremy R Jass; Alessandro Lugli
Role of RHAMM within the hierarchy of well-established prognostic factors in colorectal cancer.
Gut 2008;57(10):1413-9.
2008: Inti Zlobec; A Lugli
Prognostic and predictive factors in colorectal cancer.
Postgraduate medical journal 2008;84(994):403-11.
2008: Inti Zlobec; Kristi Baker; Luigi M Terracciano; Alessandro Lugli
RHAMM, p21 combined phenotype identifies microsatellite instability-high colorectal cancers with a highly adverse prognosis.
Clinical cancer research : an official journal of the American Association for Cancer Research 2008;14(12):3798-806.
2008: Inti Zlobec; Luigi Terracciano; Alessandro Lugli
Local recurrence in mismatch repair-proficient colon cancer predicted by an infiltrative tumor border and lack of CD8+ tumor-infiltrating lymphocytes.
Clinical cancer research : an official journal of the American Association for Cancer Research 2008;14(12):3792-7.
2008: Sylvia C Wetli; Ivo Leuschner; Dieter Harms; Alex Rufle; Anja Foerster; Michel Bihl; Norbert Graf; Roikos Furtwaengler; Michael Paulussen; Jakob Briner; Charalampos Aslanidis; Gerd Schmitz; Luigi Tornillo; Michael J Mihatsch; Inti Zlobec; Elisabeth Bruder
KIT, PDGFRalpha and EGFR analysis in nephroblastoma.
Virchows Archiv : an international journal of pathology 2008;452(6):637-50.
2008: Inti Zlobec; Alessandro Lugli
Prognostic and predictive factors in colorectal cancer.
Journal of clinical pathology 2008;61(5):561-9.
2008: Inti Zlobec; Parham Minoo; Daniel Baumhoer; Kristi Baker; Luigi Terracciano; Jeremy R Jass; Alessandro Lugli
Multimarker phenotype predicts adverse survival in patients with lymph node-negative colorectal cancer.
Cancer 2008;112(3):495-502.
2008: Inti Zlobec; Té Vuong; Carolyn Corlies Compton; Alessandro Lugli; René P Michel; S Hayashi; Jeremy R Jass
Combined analysis of VEGF and EGFR predicts complete tumour response in rectal cancer treated with preoperative radiotherapy.
British journal of cancer 2008;98(2):450-6.
2008: Inti Zlobec; Kristi Baker; Parham Minoo; Jeremy R Jass; Luigi Terracciano; Alessandro Lugli
Node-negative colorectal cancer at high risk of distant metastasis identified by combined analysis of lymph node status, vascular invasion, and Raf-1 kinase inhibitor protein expression.
Clinical cancer research : an official journal of the American Association for Cancer Research 2008;14(1):143-8.
2007: Inti Zlobec; Luigi Terracciano; Jeremy R Jass; Alessandro Lugli
Value of staining intensity in the interpretation of immunohistochemistry for tumor markers in colorectal cancer.
Virchows Archiv : an international journal of pathology 2007;451(4):763-9.
2007: Inti Zlobec; Russell Steele; Luigi Terracciano; Jeremy R Jass; Alessandro Lugli
Selecting immunohistochemical cut-off scores for novel biomarkers of progression and survival in colorectal cancer.
Journal of clinical pathology 2007;60(10):1112-6.
2007: Inti Zlobec; Alessandro Lugli; Kristi Baker; S Roth; Parham Minoo; S Hayashi; Luigi Terracciano; Jeremy R Jass
Role of APAF-1, E-cadherin and peritumoral lymphocytic infiltration in tumour budding in colorectal cancer.
The Journal of pathology 2007;212(3):260-8.
2007: Parham Minoo; Inti Zlobec; Kristi Baker; Luigi Tornillo; Luigi Terracciano; Jeremy R Jass; Alessandro Lugli
Loss of raf-1 kinase inhibitor protein expression is associated with tumor progression and metastasis in colorectal cancer.
American journal of clinical pathology 2007;127(5):820-7.
2007: Alessandro Lugli; Inti Zlobec; Kristi Baker; Parham Minoo; Luigi Tornillo; Luigi Terracciano; Jeremy R Jass
Prognostic significance of mucins in colorectal cancer with different DNA mismatch-repair status.
Journal of clinical pathology 2007;60(5):534-9.
2007: Inti Zlobec; Parham Minoo; Kristi Baker; David G Haegert; Karim Khetani; Luigi Tornillo; Luigi Terracciano; Jeremy R Jass; Alessandro Lugli
Loss of APAF-1 expression is associated with tumour progression and adverse prognosis in colorectal cancer.
European journal of cancer (Oxford, England : 1990) 2007;43(6):1101-7.
2007: Inti Zlobec; Té Vuong; S Hayashi; David G Haegert; Luigi Tornillo; Luigi Terracciano; Alessandro Lugli; J Jass
A simple and reproducible scoring system for EGFR in colorectal cancer: application to prognosis and prediction of response to preoperative brachytherapy.
British journal of cancer 2007;96(5):793-800.
2007: Alessandro Lugli; Inti Zlobec; Parham Minoo; Kristi Baker; Luigi Tornillo; Luigi Terracciano; Jeremy R Jass
Prognostic significance of the wnt signalling pathway molecules APC, beta-catenin and E-cadherin in colorectal cancer: a tissue microarray-based analysis.
Histopathology 2007;50(4):453-64.
2007: Parham Minoo; Inti Zlobec; Kristi Baker; Luigi Tornillo; Luigi Terracciano; Jeremy R Jass; Alessandro Lugli
Prognostic significance of mammalian sterile20-like kinase 1 in colorectal cancer.
Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc 2007;20(3):331-8.
2007: Kristi Baker; Inti Zlobec; Luigi Tornillo; Luigi Terracciano; Jeremy R Jass; Alessandro Lugli
Differential significance of tumour infiltrating lymphocytes in sporadic mismatch repair deficient versus proficient colorectal cancers: a potential role for dysregulation of the transforming growth factor-beta pathway.
European journal of cancer (Oxford, England : 1990) 2007;43(3):624-31.
2007: Coya Tapia; Spasenija Savic; Urs Wagner; René Schönegg; Hedvika Novotny; Bruno Grilli; Michelle Herzog; Audrey Devito Barascud; Inti Zlobec; Gieri Cathomas; Luigi Terracciano; Georg Feichter; Lukas Bubendorf
HER2 gene status in primary breast cancers and matched distant metastases.
Breast cancer research : BCR 2007;9(3):R31.
2007: Alessandro Lugli; Inti Zlobec; Gad Singer; Andrea Kopp Lugli; Luigi Terracciano; Robert Genta
Napoleon Bonaparte's gastric cancer: a clinicopathologic approach to staging, pathogenesis, and etiology.
Nature clinical practice. Gastroenterology & hepatology 2007;4(1):52-7.
2007: Luigi Tornillo; Alessandro Lugli; Inti Zlobec; Niels Willi; Katharina Glatz; Frank Lehmann; Hans-Peter Spichtin; Robert Maurer; Dimitra Stoios; Guido Sauter; Luigi Terracciano
Prognostic value of cell cycle and apoptosis regulatory proteins in mismatch repair-proficient colorectal cancer: a tissue microarray-based approach.
American journal of clinical pathology 2007;127(1):114-23.
2006: Alessandro Lugli; Inti Zlobec; Ursula Günthert; Parham Minoo; Kristi Baker; Luigi Tornillo; Luigi Terracciano; Jeremy R Jass
Overexpression of the receptor for hyaluronic acid mediated motility is an independent adverse prognostic factor in colorectal cancer.
Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc 2006;19(10):1302-9.
2006: Inti Zlobec; Russell Steele; René P Michel; Carolyn Corlies Compton; Alessandro Lugli; Jeremy R Jass
Scoring of p53, VEGF, Bcl-2 and APAF-1 immunohistochemistry and interobserver reliability in colorectal cancer.
Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc 2006;19(9):1236-42.
2006: Jeremy R Jass; Kristi Baker; Inti Zlobec; T Higuchi; M Barker; D Buchanan; J Young
Advanced colorectal polyps with the molecular and morphological features of serrated polyps and adenomas: concept of a 'fusion' pathway to colorectal cancer.
Histopathology 2006;49(2):121-31.
2006: Alessandro Lugli; Inti Zlobec; Parham Minoo; Kristi Baker; Luigi Tornillo; Luigi Terracciano; Jeremy R Jass
Role of the mitogen-activated protein kinase and phosphoinositide 3-kinase/AKT pathways downstream molecules, phosphorylated extracellular signal-regulated kinase, and phosphorylated AKT in colorectal cancer-a tissue microarray-based approach.
Human pathology 2006;37(8):1022-31.
2006: Inti Zlobec; Té Vuong; Carolyn Corlies Compton
The predictive value of apoptosis protease-activating factor 1 in rectal tumors treated with preoperative, high-dose-rate brachytherapy.
Cancer 2006;106(2):284-6.
2005: Inti Zlobec; Russell Steele; Carolyn Corlies Compton
VEGF as a predictive marker of rectal tumor response to preoperative radiotherapy.
Cancer 2005;104(11):2517-21.
2005: Inti Zlobec; Russell Steele; Nilima Nigam; Carolyn Corlies Compton
A predictive model of rectal tumor response to preoperative radiotherapy using classification and regression tree methods.
Clinical cancer research : an official journal of the American Association for Cancer Research 2005;11(15):5440-3.